HomeOwner SearchCategory Search
Visit USCODiabetes Technology & Therapeutics [Published: 2017-07-27 to 2017-09-28. Issues: vol. 19, no. 7, July 2017 to vol. 19, no. 9, September 2017]
Serial Registration
Copyright Title
Diabetes Technology & Therapeutics [Published: 2017-07-27 to 2017-09-28. Issues: vol. 19, no. 7, July 2017 to vol. 19, no. 9, September 2017]
Status
Published
on 8 Jun 2018
Year of Creation
2017
Copyright Claimant
Mary Ann Liebert, Inc
Registration Number
TX0008584826
on 8 Jun 2018Copyright Summary
The U.S. Copyright record (Registration Number: TX0008584826) dated 8 Jun 2018, pertains to an electronic file (eService) titled "Diabetes Technology & Therapeutics [Published: 2017-07-27 to 2017-09-28. Issues: vol. 19, no. 7, July 2017 to vol. 19, no. 9, September 2017]" created in 2017. The copyright holder is Mary Ann Liebert, Inc, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Mary Ann Liebert, Inc.
Application Details
Registration Number
TX0008584826
Registration Date
6/8/2018
Year of Creation
2017
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Mary Ann Liebert, Inc
First Publication Nation
United States
ISSN
1520-9156
Notes
Copyright Local Holdings: vol. 19, no. 7, July 2017 Pub. 2017-07-27 Reg. 2018-04-10 TX0008584826 STEKvol. 19, no. 8, August 2017 Pub. 2017-08-24 Reg. 2018-04-10 TX0008584826 STEKvol. 19, no. 9, September 2017 Pub. 2017-09-28 Reg. 2018-04-10 TX0008584826 STEK
Statements
Application Title Statement: Diabetes Technology & Therapeutics
Author Statement: Mary Ann Liebert, Inc employer for hire Authorship: Collective Work
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.